MedTrace Logo

Impact on Hypoglycaemia Awareness of Real Time CGM and Intermittent Continuous Glucose Data

NCT03028220 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2019-11-13

Study results available
· View outcomes & findings →

Summary

This clinical study proposes to assess the impact of Libre on frequency, duration and severity of hypoglycaemia, compared with the Dexcom G5 realtime CGM and will focus on people with impaired awareness of hypoglycaemia.

Conditions

  • Type 1 Diabetes Mellitus With Hypoglycemia
  • Impaired Awareness of Hypoglycemia
  • Type1diabetes

Interventions

DEVICE

Dexcom G5 Continuous Glucose Monitor

Real time continuous glucose sensor connected to monitor providing data and alarms and alerts for glucose trends and values

DEVICE

Abbott Freestyle Libre

Continuous glucose recording device which reports glucose concentration and trend on demand, along with a retrospective review of the last 8 hours glucose data

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Principal Investigators

  • Nick Oliver, FRCP · Imperial College London

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2017-02-28
Completion
2017-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03028220 on ClinicalTrials.gov